Sandip Prasad, MD, MPhil

Sandip Prasad, MD, MPhil, Garden State Urology, Atlantic Health System

Articles by Sandip Prasad, MD, MPhil

Updated ENVISION Data: UGN-102 Shows 82.3% Duration of Response in LG-IR-NMIBC

Sandip Prasad, MD, MPhilNon-Muscle Invasive Urothelial Carcinoma | June 26, 2024

Dr. Prasad provides updates on the positive DOR data observed with UGN-102 for LG-IR-NMIBC in the ENVISION trial.

Dr. Sandip Prasad on ATLAS and ENVISION for Intermediate-Risk, Low-Grade NMIBC

Sandip Prasad, MD, MPhilNon-Muscle Invasive Urothelial Carcinoma | August 30, 2023

Dr. Prasad provides overviews of ATLAS and ENVISION and opines on whether UGN-102 is a practice-ready alternative to TURBT.